Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Aminolevulinic Acid Hexylester
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Asieris Announces NDA Acceptance for Regulatory Review of Cevira in China
Details :
Product Name : Cevira
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
December 05, 2024
Lead Product(s) : Aminolevulinic Acid Hexylester
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Aminolevulinic Acid Hexylester
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : Photocure
Deal Size : Inapplicable
Deal Type : Inapplicable
Details :
Product Name : Cevira
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
September 20, 2023
Lead Product(s) : Aminolevulinic Acid Hexylester
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : Photocure
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Aminolevulinic Acid Hexylester
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details :
Product Name : Cevira
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 25, 2022
Lead Product(s) : Aminolevulinic Acid Hexylester
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Aminolevulinic Acid Hexylester
Therapeutic Area : Oncology
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
APL-1702 International Multicenter Phase III Clinical Trial of the First Patient in Asia Hong
Details :
Product Name : Cevira
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
November 11, 2020
Lead Product(s) : Aminolevulinic Acid Hexylester
Therapeutic Area : Oncology
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Aminolevulinic Acid Hexylester
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Study Phase : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable
Details :
Product Name : Cevira
Product Type : Other Small Molecule
Upfront Cash : Inapplicable
August 07, 2020
Lead Product(s) : Aminolevulinic Acid Hexylester
Therapeutic Area : Obstetrics/Gynecology (Women’s Health)
Highest Development Status : Phase III
Sponsor : Inapplicable
Deal Size : Inapplicable
Deal Type : Inapplicable